“…In a very recent study, a detailed rationalization of guest encapsulation and release mechanisms was performed with the aim of understanding the drug delivery kinetics of most emerging CPPs and, consequently, to fully assess their potential use as nanocarriers for therapeutic purposes [50]. Thus, two morphologically equivalent CPPs based on cobalt with general composition [Co(bix)(3,5-dbsq)(3,5-dbcat)] were used as carriers, where bix is a flexible bis-imidazole bridging ligand and 3,5-dbsq and 3,5-dbcat stand for the semiquinonate radical and catecholate forms of 3,5-di-tert-butylcatechol.…”